Neuro-Oncology: The Podcast

Host: Evan Noch; Interviewees: Jasia Mahdi, Jacob Young, Alireza Mansouri Evan Noch interviews the Co-chairs of SNO's Young Investigator Committee about their advice on career journeys for early-career trainees  

Host: Akanksha Sharma, MD Interviewee: Shannon Thomas, RN, MSN   Podcast Description: Dr Sharma has a candid, reflective conversation with Shannon Thomas, CEO of Eden Medical Center in Castro Valley, CA, and the wife of Dr. Ronnie Mimran – a beloved physician and highly skilled neurosurgeon known for his patient care and bedside manner. Dr Mimran is living with glioblastoma; he was diagnosed almost 3 years ago. We discuss her perspective as not only a caregiver but a nurse and healthcare executive, and what they have learned on this journey.

Podcast Host and Interviewee: Host: John Fortunato Interviewee: Sofia Rael, Ugur Sener    Podcast Description: Dr. John Fortunato interviews Dr. Sofia Rael and Dr. Ugur Sener on their recent manuscript, titled "Ivosidenib in predominantly recurrent IDH1-mutant glioma: A single institution experience."

·      Podcast Host and Interviewee:  Host: Maya GrahamInterviewee: Santiago Cepeda Description  Dr. Maya Graham interviews Dr. Santiago Cepeda on his recent Neuro-oncology article entitled "Prospective biopsy-controlled validation of an AI model for predicting glioblastoma infiltration: Results from the SupraGlio trial."

Host/Interviewee: ç, PhD Candidate, UT Health San Antonio Description: Shahad Abdulsahib discusses the GT-20 phase 1 clinical trial evaluating GNOS-PV01, a personalized multivalent neoantigen DNA vaccine administered following surgical resection and radiation in patients with MGMT unmethylated glioblastoma, with findings published in Nature Cancer on May 12th, 2026.

Podcast Host and Interviewee: Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai   Dr. Haseeb Mehmood Qadri interviews Prof. Dr. Ghazaleh Tabatabai from the Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Germany on their manuscript, entitled Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort

Podcast Host and Interviewee: Rachna Malani, Sarah Menacho, Ben Shofty Rachna Malani interviews Drs. Menacho and Shofty, two Neurosurgeons who share their experiences in interfacing with Neurosurgery as well as their experiences as Neurosurgeons.

Podcast Host and Interviewee: Venina Kalistratova (host), Nick Gonzalez Castro and Raj Mukherjee (Interviewees) Podcast Description: The Co-chairs of the SNO Wellness Committee discuss wellness and ways to reduce burnout.

Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025

Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee)      Podcast Description:  Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology 

Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee)    Podcast Description:  Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology

Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff   Podcast Description:  Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma"

Podcast Host and Interviewee: Host: Dr. Dave Rogawski Interviewee: Dr. Fabio Iwamoto Dr. Dave Rogawski interviews Dr. Fabio Iwamoto, incoming Neuro-Oncology Division Chief at Stanford, about where we're headed in neuro-oncology.  

Podcast Host and Interviewee: Evan Noch, Producer, Neuro-oncology: The Podcast Podcast Description: Evan Noch discusses recent career development outreach from SNO

Podcast Host and Interviewee:  Host: Sara Hardy;  Interviewee: Caroline Catlin   Caroline Catlin is an artist and also a brain tumor survivor. Her writing and photography can be found in The New York Times, Longreads, Huffington Post, Glamour, and elsewhere. She has an MFA in Writing from Pacific University and a forthcoming memoir in progress, represented by Neon Literary.   Her TED talk, Why I Photograph the Quiet Moments of Grief and Loss, has been viewed over 1 million times. In this interview, she talks about how her diagnosis changed her life and how her art helped her to cope and thrive.

Podcast Host and Interviewee:  Host: John Fortunato Interviewee: Bob Jenkins  Podcast Description: Dr. John Fortunato interviews Dr. Bob Jenkins on his recent manuscript, titled "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma."

Dr. Dave Rogawski interviews Dr. Mary Jane (MJ) Lim-Fat and Dr. Kee Kiat (Aaron) Yeo on patient care and research for the adolescent and young adult (AYA) population in neuro-oncology.

Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular bivalent EGFR and IL13Rα2 CAR T cells for recurrent glioblastoma, published in Nature Medicine.

Jayden Hang and Dr. Michael Dohopolski interview Dr. Brooke Braman about her training path as a radiation oncology resident.

 In this episode of Author Interviews, Dr. Jiasen He speaks with Dr. Margit K. Mikkelsen and Dr. Daniel C. Moreira from St. Jude Children's Research Hospital about their article, "Global Analysis of Clinical Trials for Children and Adolescents with CNS Tumors," published in Neuro-Oncology Pediatrics.

Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma, published in Nature Medicine in January 2025.

Dr. Sara Hardy interviews Drs. Ashlee Loughan and Sarah Brahn to talk about their groundbreaking work to improve quality of life for patients with brain tumors.

Dr. John Fortunato interviews Dr. Stefania Picariello and Dr. Enrico Opocher on their manuscript, entitled "Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma."

 Dr. Dave Rogawski interviews Dr. Akanksha Sharma on how we can optimize the meaningful, longitudinal relationships that drew many of us to the field.

Podcast Host and Interviewee: Shahad Abdulsahib, PhD Candidate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a recent Phase 1 clinical trial on Rhenium-186 nanoliposome therapy for recurrent glioma, published in Nature Communications in March 2025.

Dr. Alex Landry interviews Dr. Gelareh Zadeh on her career in academic neurosurgical oncology, focusing on the role of mentorship, how the field has evolved over time, and advice for junior trainees entering the field.   

Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.

Dr. Nathan Dalton interviews Dr. Joseph Sia on the topic of radiation hypofractionation – its history, current clinical landscape, and potential future developments for patients with gliomas.

Shahad Abdulsahib discusses the findings of a recent paper, entitled "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma", which was published in Nature Communications in December 2025.

Dr. Rachna Malani interviews Mindy Freund about her work at the American Brain Tumor Association

Dr. Jasmin Jo interviews Dr. Amy Smith and Dr. David Ellison on their manuscript, entitled "Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology Group" published in Neuro-Oncology in December 2025.

Dr. Dave Rogawski interviews Dr. David Solomon on his research that sheds light on how key genomic alterations in high-grade glioma evolve over time and how these insights might inform therapeutic development.

Dr. Haseeb Mehmood discusses the use of microbubble-enhanced transcranial focused ultrasound combined with standard temozolomide in high-grade glioma.

Dr. Evan Noch interviews Dr. Lisa DeAngelis about her career in neuro-oncology, role as Chair of Neurology and Physician-in-Chief at Memorial Sloan Kettering Cancer Center, and advice for trainees entering the field.

Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.

In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.

Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.

Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: "Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation", published online in Neuro-Oncology in July 2025.

Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.

Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.

Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf130/8151442

Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025   Link: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf059/8058778

Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.

Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025.   More Information

Dr. Iyad Alnahhas interviews Dr. Peter LaViolette about his and his team's recent manuscript entitled: "Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps", published online in Neuro-Oncology in February 2025.

Description: Dr. Evan Noch interviews Drs. Cecile Riviere-Cazaux and Terry Burns about their recent manuscript entitled: "A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery", published online in Neuro-Oncology in December 2024.   Link: https://doi.org/10.1093/neuonc/noae277  

Description: Dr. Ankush Bhatia interviews Drs. Macarena de la Fuente and Mehdi Touat about their recent manuscript entitled: "The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma" published online in Neuro-Oncology in December 2024.   Link: https://doi.org/10.1093/neuonc/noae259

Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

Dr. Iyad Alnahhas interviews Dr. Danielle Bazer about her and her team's recently published manuscript, entitled: Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma", published online in Neuro-Oncology in November 2024.